ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/5/2023ACC: 0001209191-23-041139
Officer· Interim CFO
Since Jun 2021
-91.00
Net shares
Net seller
$373.10
Total sold
0
Open market trades
0B · 0S
1
Total transactions
91.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−91.00
Price / share
$4.10
Trade value
$373.10
% of position
1.1%
6/30/2023
8.11K→8.02K
Total
Net shares
−91.00
Net value
-$373.10
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2023 | F · Tax Withholding | −91.00 | $4.10 | $373.10 | 1.1% | 8.11K | 8.02K |
| Total | −91.00 | -$373.10 | ||||||
Derivative Transactions0
No derivative transactions reported